DSGN
Design Therapeutics Inc
12.30$
-0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +3.6% | +5.6% | +1.3% | -2.6% | +6.7% | -4.4% | +2.0% | +0.6% | +0.6% | -3.8% | – | |
| – | -15.4% | +16.9% | +3.6% | -5.5% | +11.3% | +2.0% | +12.6% | -9.9% | -4.3% | +14.2% | -1.5% | – | |
| – | – | – | – | – | -3.9% | -206.0% | – | +188.1% | -66.5% | -391.5% | – | – | |
| – | -49.1% | +622.2% | -17.4% | -90.1% | -100.0% | – | +20.8% | -100.0% | – | -100.0% | – | – | |
| – | -63.6% | +271.1% | +32.6% | -121.3% | – | +329.6% | +155.6% | -67.6% | -277.9% | -34.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3,753.8% | -96.0% | +1,045.0% | -99.6% | +26,200.0% | -91.3% | +1,469.6% | -89.8% | +68,324.3% | -21.3% | -97.0% | – | |
| – | -1,005.0% | – | +98.9% | -194.3% | – | – | – | -176.5% | – | -331.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.